Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 519459
[patent_doc_number] => 07186414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-06
[patent_title] => 'Compounds and compositions for delivering active agents'
[patent_app_type] => utility
[patent_app_number] => 11/173075
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10901
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/186/07186414.pdf
[firstpage_image] =>[orig_patent_app_number] => 11173075
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/173075 | Compounds and compositions for delivering active agents | Jun 29, 2005 | Issued |
Array
(
[id] => 6926435
[patent_doc_number] => 20050239691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Cross-linked glycopeptide - cephalosporin antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/172303
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17058
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239691.pdf
[firstpage_image] =>[orig_patent_app_number] => 11172303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/172303 | Cross-linked glycopeptide—cephalosporin antibiotics | Jun 29, 2005 | Issued |
Array
(
[id] => 5880585
[patent_doc_number] => 20060029667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents'
[patent_app_type] => utility
[patent_app_number] => 11/170652
[patent_app_country] => US
[patent_app_date] => 2005-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28894
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029667.pdf
[firstpage_image] =>[orig_patent_app_number] => 11170652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/170652 | Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents | Jun 28, 2005 | Issued |
Array
(
[id] => 5793989
[patent_doc_number] => 20060014670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Compositions and methods for the prevention and control of insulin-induced hypoglycemia'
[patent_app_type] => utility
[patent_app_number] => 11/169825
[patent_app_country] => US
[patent_app_date] => 2005-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31621
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014670.pdf
[firstpage_image] =>[orig_patent_app_number] => 11169825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/169825 | Compositions and methods for the prevention and control of insulin-induced hypoglycemia | Jun 27, 2005 | Issued |
Array
(
[id] => 5716082
[patent_doc_number] => 20060079445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'CaMKII/calcium channel binding-related compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/155164
[patent_app_country] => US
[patent_app_date] => 2005-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16389
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11155164
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/155164 | CaMKII/calcium channel binding-related compositions and methods | Jun 15, 2005 | Abandoned |
Array
(
[id] => 5297339
[patent_doc_number] => 20090012265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Purification of polymers carrying a lipophilic group'
[patent_app_type] => utility
[patent_app_number] => 11/597805
[patent_app_country] => US
[patent_app_date] => 2005-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8002
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012265.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597805
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597805 | Purification of polymers carrying a lipophilic group | May 29, 2005 | Abandoned |
Array
(
[id] => 5881436
[patent_doc_number] => 20060030519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Composition for reducing blood lipids'
[patent_app_type] => utility
[patent_app_number] => 11/137498
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2018
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20060030519.pdf
[firstpage_image] =>[orig_patent_app_number] => 11137498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/137498 | Composition for reducing blood lipids | May 25, 2005 | Abandoned |
Array
(
[id] => 5210956
[patent_doc_number] => 20070249540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Methods for Inhibiting Proteasome and Heat Shock Protein 90'
[patent_app_type] => utility
[patent_app_number] => 11/597345
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6557
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597345
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597345 | Methods for Inhibiting Proteasome and Heat Shock Protein 90 | May 22, 2005 | Abandoned |
Array
(
[id] => 5739002
[patent_doc_number] => 20060009393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Immunogenic epitopes for fibroblast growth factors 5 (FGF-5)'
[patent_app_type] => utility
[patent_app_number] => 11/134703
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 33767
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009393.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134703
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134703 | Immunogenic epitopes for fibroblast growth factors 5 (FGF-5) | May 18, 2005 | Abandoned |
Array
(
[id] => 196359
[patent_doc_number] => 07638283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-29
[patent_title] => 'Amyloid β protein (globular assembly and uses thereof)'
[patent_app_type] => utility
[patent_app_number] => 11/130566
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6669
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/638/07638283.pdf
[firstpage_image] =>[orig_patent_app_number] => 11130566
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/130566 | Amyloid β protein (globular assembly and uses thereof) | May 15, 2005 | Issued |
Array
(
[id] => 10070697
[patent_doc_number] => 09109041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification'
[patent_app_type] => utility
[patent_app_number] => 11/579615
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15467
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11579615
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579615 | Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification | May 5, 2005 | Issued |
Array
(
[id] => 5769334
[patent_doc_number] => 20060019972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Methods of treating cancer by inhibiting histone gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/116959
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21567
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019972.pdf
[firstpage_image] =>[orig_patent_app_number] => 11116959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/116959 | Methods of treating cancer by inhibiting histone gene expression | Apr 26, 2005 | Abandoned |
Array
(
[id] => 6931205
[patent_doc_number] => 20050282240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Method for identifying peptides in a biological sample'
[patent_app_type] => utility
[patent_app_number] => 11/114629
[patent_app_country] => US
[patent_app_date] => 2005-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9314
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282240.pdf
[firstpage_image] =>[orig_patent_app_number] => 11114629
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/114629 | Method for identifying peptides in a biological sample | Apr 25, 2005 | Issued |
Array
(
[id] => 7069039
[patent_doc_number] => 20050244422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress'
[patent_app_type] => utility
[patent_app_number] => 11/109161
[patent_app_country] => US
[patent_app_date] => 2005-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13337
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11109161
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/109161 | Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress | Apr 17, 2005 | Abandoned |
Array
(
[id] => 5200218
[patent_doc_number] => 20070299536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Collagen Mimics'
[patent_app_type] => utility
[patent_app_number] => 10/599926
[patent_app_country] => US
[patent_app_date] => 2005-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6186
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599926 | Collagen Mimics | Apr 13, 2005 | Abandoned |
Array
(
[id] => 865068
[patent_doc_number] => 07368529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-06
[patent_title] => 'Agent and compositions comprising the same for inhibiting lipases and phospholipases in body fluids, cells and tissues'
[patent_app_type] => utility
[patent_app_number] => 11/093637
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5055
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368529.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093637
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093637 | Agent and compositions comprising the same for inhibiting lipases and phospholipases in body fluids, cells and tissues | Mar 29, 2005 | Issued |
Array
(
[id] => 5271067
[patent_doc_number] => 20090074843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Use of epi-hne 1-4'
[patent_app_type] => utility
[patent_app_number] => 11/547167
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2700
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547167 | Use of epi-hne 1-4 | Mar 29, 2005 | Abandoned |
Array
(
[id] => 9427618
[patent_doc_number] => 08703693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment'
[patent_app_type] => utility
[patent_app_number] => 11/547072
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3553
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11547072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547072 | Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment | Mar 29, 2005 | Issued |
Array
(
[id] => 7112243
[patent_doc_number] => 20050209699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor'
[patent_app_type] => utility
[patent_app_number] => 11/092265
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6816
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209699.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092265
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092265 | Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor | Mar 28, 2005 | Abandoned |
Array
(
[id] => 5794016
[patent_doc_number] => 20060014697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Pharmaceutical compositions for prevention of overdose or abuse'
[patent_app_type] => utility
[patent_app_number] => 11/089056
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 144
[patent_figures_cnt] => 144
[patent_no_of_words] => 28143
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014697.pdf
[firstpage_image] =>[orig_patent_app_number] => 11089056
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/089056 | Pharmaceutical compositions for prevention of overdose or abuse | Mar 24, 2005 | Abandoned |